Show source-provided references
1. Dimitriou, R., Jones, E., McGonagle, D., and Giannoudis, P.V. (2011). Bone Regeneration: Current Concepts and Future Directions. BMC Med., 9.
10.1186/1741-7015-9-66 ↗2. Oxidized Alginate Hydrogels with the GHK Peptide Enhance Cord Blood Mesenchymal Stem Cell Osteogenesis: A Paradigm for Metabolomics-Based Evaluation of Biomaterial Design
10.1016/j.actbio.2019.02.017 ↗4. Understanding and Leveraging Cell Metabolism to Enhance Mesenchymal Stem Cell Transplantation Survival in Tissue Engineering and Regenerative Medicine Applications
10.1002/stem.3079 ↗7. Migdadi, L., Sharar, N., Jafar, H., Telfah, A., Hergenröder, R., and Wöhler, C. (2023). Machine Learning in Automated Monitoring of Metabolic Changes Accompanying the Differentiation of Adipose-Tissue-Derived Human Mesenchymal Stem Cells Employing 1H-1H TOCSY NMR. Metabolites, 13.
10.3390/metabo13030352 ↗8. Development of a Robust Consensus Modeling Approach for Identifying Cellular and Media Metabolites Predictive of Mesenchymal Stromal Cell Potency
10.1093/stmcls/sxad039 ↗10. Metabolomics Analysis of the Osteogenic Differentiation of Umbilical Cord Blood Mesenchymal Stem Cells Reveals Differential Sensitivity to Osteogenic Agents
10.1089/scd.2016.0315 ↗11. RGD-Functionalized Polyurethane Scaffolds Promote Umbilical Cord Blood Mesenchymal Stem Cell Expansion and Osteogenic Differentiation
14. Vernardis, S.I., Terzoudis, K., Panoskaltsis, N., and Mantalaris, A. (2017). Human Embryonic and Induced Pluripotent Stem Cells Maintain Phenotype but Alter Their Metabolism after Exposure to ROCK Inhibitor. Sci. Rep., 7.
10.1038/srep42138 ↗16. Differential Expression of Cell Cycle and WNT Pathway-Related Genes Accounts for Differences in the Growth and Differentiation Potential of Wharton’s Jelly and Bone Marrow-Derived Mesenchymal Stem Cells
10.1186/s13287-017-0555-9 ↗17. Distinct Differentiation Potential of “MSC” Derived from Cord Blood and Umbilical Cord: Are Cord-Derived Cells True Mesenchymal Stromal Cells?
10.1089/scd.2011.0414 ↗18. Rybkowska, P., Radoszkiewicz, K., Kawalec, M., Dymkowska, D., Zabłocka, B., Zabłocki, K., and Sarnowska, A. (2023). The Metabolic Changes between Monolayer (2D) and Three-Dimensional (3D) Culture Conditions in Human Mesenchymal Stem/Stromal Cells Derived from Adipose Tissue. Cells, 12.
10.3390/cells12010178 ↗19. Osteogenic Commitment of Wharton’s Jelly Mesenchymal Stromal Cells: Mechanisms and Implications for Bioprocess Development and Clinical Application
10.1186/s13287-019-1450-3 ↗21. The Use of ’Omics Technology to Rationally Improve Industrial Mammalian Cell Line Performance
10.1002/bit.25673 ↗23. Capelli, C., Cuofano, C., Pavoni, C., Frigerio, S., Lisini, D., Nava, S., Quaroni, M., Colombo, V., Galli, F., and Bezukladova, S. (2023). Potency Assays and Biomarkers for Cell-Based Advanced Therapy Medicinal Products. Front. Immunol., 14.
10.3389/fimmu.2023.1186224 ↗24. ATMP development and pre-GMP environment in academia: A safety net for early cell and gene therapy development and manufacturing
10.1016/j.iotech.2022.100099 ↗25. Manzini, P., Peli, V., Rivera-Ordaz, A., Budelli, S., Barilani, M., and Lazzari, L. (2022). Validation of an automated cell counting method for cGMP manufacturing of human induced pluripotent stem cells. Biotechnol. Rep., 33.
10.1016/j.btre.2022.e00708 ↗27. Lechanteur, C., Briquet, A., Bettonville, V., Baudoux, E., and Beguin, Y. (2021). MSC Manufacturing for Academic Clinical Trials: From a Clinical-Grade to a Full GMP-Compliant Process. Cells, 10.
10.3390/cells10061320 ↗30. Integrating metabolome dynamics and process data to guide cell line selection in biopharmaceutical process development
10.1016/j.ymben.2022.03.015 ↗33. Metabolic Regulation of Stem Cells and Differentiation: A Forkhead Box O Transcription Factor Perspective
10.1089/ars.2020.8126 ↗36. Rajput, D., Wang, W.J., and Chen, C.C. (2023). Evaluation of a decided sample size in machine learning applications. BMC Bioinform., 24.
10.1186/s12859-023-05156-9 ↗37. Dhiman, P., Ma, J., Qi, C., Bullock, G., Sergeant, J.C., Riley, R.D., and Collins, G.S. (2023). Sample size requirements are not being considered in studies developing prediction models for binary outcomes: A systematic review. BMC Med. Res. Methodol., 23.
10.1186/s12874-023-02008-1 ↗39. Noise injection for training artificial neural networks: A comparison with weight decay and early stopping
10.1118/1.3213517 ↗41. Snell, K.I.E., Allotey, J., Smuk, M., Hooper, R., Chan, C., Ahmed, A., Chappell, L.C., Von Dadelszen, P., Green, M., and Kenny, L. (2020). External validation of prognostic models predicting pre-eclampsia: Individual participant data meta-analysis. BMC Med., 18.
10.1186/s12916-020-01766-9 ↗42. TRIPOD+AI statement: Updated guidance for reporting clinical prediction models that use regression or machine learning methods
10.1136/bmj-2023-078378 ↗